The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular...

Area of Science:

• Neuroscience
• Biochemistry
• Structural Biology

Background:

• Protein aggregation into oligomers is central to neurodegenerative diseases.
• Soluble oligomers are considered key toxic species.
• Identifying structural determinants of oligomer toxicity is crucial for understanding disease mechanisms.

Purpose of the Study:

• To analyze toxic alpha-synuclein oligomers and their variants.
• To identify structural features linked to toxicity.
• To investigate a novel structural polymorphism in G51D oligomers.

Main Methods:

• Analysis of toxic alpha-synuclein oligomers and pathological variants.
• Structural characterization of G51D oligomers.
• Correlation of oligomer structure with cellular dysfunction in SH-SY5Y cells.

Main Results:

• A novel structural polymorphism was identified within G51D oligomers.
• These oligomers exhibit diverse beta-sheet-rich structures with varying alpha-helical content.
• Higher alpha-helical content in G51D oligomers correlated with increased cellular dysfunction.

Conclusions:

• Alpha-helical structure content is a potential determinant of cellular toxicity in alpha-synuclein oligomers.
• This structure-function relationship provides insights into the toxicity of amyloid-related proteins.
• Findings advance understanding of molecular mechanisms in neurodegenerative diseases.